0000950170-24-103955.txt : 20240905 0000950170-24-103955.hdr.sgml : 20240905 20240905160002 ACCESSION NUMBER: 0000950170-24-103955 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240903 FILED AS OF DATE: 20240905 DATE AS OF CHANGE: 20240905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Warren Lucinda CENTRAL INDEX KEY: 0002035620 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 241281317 MAIL ADDRESS: STREET 1: C/O CUE BIOPHARMA, INC. STREET 2: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 ownership.xml 4 X0508 4 2024-09-03 false 0001645460 Cue Biopharma, Inc. CUE 0002035620 Warren Lucinda C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 false true false false CHIEF BUSINESS OFFICER false Stock Option (right to buy) 0.66 2024-09-03 4 A false 350000 0.0 A 2034-09-02 Common Stock 350000 350000 D This stock option becomes exercisable in four equal semi-annual installments beginning on March 3, 2025. /s/ Lucinda Warren by Colin Sandercock, attorney-in-fact 2024-09-05